April 15 (Reuters) – The U.S. Food and Drug Administration
on Friday rejected Chiasma Inc’s drug to treat adults
with a type of growth disorder.
The post U.S. FDA rejects Chiasma’s drug to treat growth disorder appeared first on NASDAQ.
Forex – financial instrument.Forex news
April 15 (Reuters) – The U.S. Food and Drug Administration
on Friday rejected Chiasma Inc’s drug to treat adults
with a type of growth disorder.
The post U.S. FDA rejects Chiasma’s drug to treat growth disorder appeared first on NASDAQ.